[
  {
    "sentence": "Among other monoclonal antibody targets, nivolumab and pembrolizumab are monoclonal antibodies targeting PD-1 receptor on T cells, B cells and NK (natural killer) cells inhibiting its binding to PD-L1 (Figure 1a), allowing the positive signaling of IFN-γ (interferon gamma) and activating the intracellular expression of anti-proliferation and pro-apoptosis genes [3,5,36].",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "Panel a",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "Panel a",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "Figure 1: Mechanisms of action for immunotherapy as a monotherapy and the immunogenic effects of radiotherapy in brain tumors.",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "The CAR (Figure 1b) consists of an artificial B cell receptor with variable antigen receptor domain specific to a unique tumor expressed antigen fused with the T cells CD3 TCR (CD 3-zeta) intracytoplasmic domain.",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "Panel b",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "Panel b",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "The systemic increase in antigen recognition has been shown to induce T cell-mediated inhibition of untreated metastatic disease (the abscopal effect) [59,60] (Figure 1c).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "Panel c",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "Panel c",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "A summary of these imaging modalities and the quantities they measure is provided in Table 2; examples of some of these modalities may be found in Figure 3.",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "Figure 3 shows an example of both contrast-enhanced T1-weighted and T2-FLAIR MRI in a patient with a high-grade glioma.",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "Figure 3 shows an example of an ADC and FA map in a patient with a high-grade glioma.",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "Figure 2 shows a graphical representation of common mathematical terms employed to simplify the complex dynamics of tumor growth into two major contributing factors, proliferation, and invasion [21].",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "Figure 2: Graphical representation of diffusion, advection, and reaction (or proliferation) terms commonly employed in models of tumor growth and response.",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "Throughout this section the reader is referred to Figure 3 which illustrates how imaging has been used in the literature to inform mathematical models of tumor growth and response.",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "Figure 4 shows a schematic of the approach in Hormuth et al. where patient specific images are used to calibrate model parameters of response to radiotherapy.",
    "figure_references": [
      {
        "figure_number": "Figure 4",
        "panel": "",
        "figure_key": "figure_4"
      }
    ]
  },
  {
    "sentence": "Figure 4: Application of patient-specific quantitative MRI data to personalize models of tumor growth and response.",
    "figure_references": [
      {
        "figure_number": "Figure 4",
        "panel": "",
        "figure_key": "figure_4"
      }
    ]
  },
  {
    "sentence": "The reader is encouraged to refer to Figure 5 as they go through the following section as it provides one potential schema for this patient-oriented modeling approach.",
    "figure_references": [
      {
        "figure_number": "Figure 5",
        "panel": "",
        "figure_key": "figure_5"
      }
    ]
  },
  {
    "sentence": "Figure 5: Imaged-based modeling for optimization of radiotherapy and immunotherapy regimens.",
    "figure_references": [
      {
        "figure_number": "Figure 5",
        "panel": "",
        "figure_key": "figure_5"
      }
    ]
  },
  {
    "sentence": "Data types required\nCentral to developing a patient-focused modeling study is the availability of serial patient-specific data characterizing the disease status and treatment effect (Figure 5a).",
    "figure_references": [
      {
        "figure_number": "Figure 5",
        "panel": "Panel a",
        "figure_key": "figure_5"
      },
      {
        "figure_number": "Figure 5",
        "panel": "Panel a",
        "figure_key": "figure_5"
      }
    ]
  },
  {
    "sentence": "Patient imaging data (and other data types) collected prior to the start of treatment and either midway or at the conclusion of treatment could be used in a mathematical framework to predict individual patient response [16,160,237] (Figure 5b).",
    "figure_references": [
      {
        "figure_number": "Figure 5",
        "panel": "Panel b",
        "figure_key": "figure_5"
      },
      {
        "figure_number": "Figure 5",
        "panel": "Panel b",
        "figure_key": "figure_5"
      }
    ]
  },
  {
    "sentence": "Once the descriptive and predictive accuracy of the mathematical model is established, the mathematical framework can be employed to investigate alternative and potentially optimal treatment regimens aimed at improving tumor control (Figure 5c).",
    "figure_references": [
      {
        "figure_number": "Figure 5",
        "panel": "Panel c",
        "figure_key": "figure_5"
      },
      {
        "figure_number": "Figure 5",
        "panel": "Panel c",
        "figure_key": "figure_5"
      }
    ]
  },
  {
    "sentence": "Among other monoclonal antibody targets, nivolumab and pembrolizumab are monoclonal antibodies targeting PD-1 receptor on T cells, B cells and NK (natural killer) cells inhibiting its binding to PD-L1 (Figure 1a), allowing the positive signaling of IFN-γ (interferon gamma) and activating the intracellular expression of anti-proliferation and pro-apoptosis genes [3,5,36].",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "Panel a",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "Panel a",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "Figure 1: Mechanisms of action for immunotherapy as a monotherapy and the immunogenic effects of radiotherapy in brain tumors.",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "The CAR (Figure 1b) consists of an artificial B cell receptor with variable antigen receptor domain specific to a unique tumor expressed antigen fused with the T cells CD3 TCR (CD 3-zeta) intracytoplasmic domain.",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "Panel b",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "Panel b",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "The systemic increase in antigen recognition has been shown to induce T cell-mediated inhibition of untreated metastatic disease (the abscopal effect) [59,60] (Figure 1c).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "Panel c",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "Panel c",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "A summary of these imaging modalities and the quantities they measure is provided in Table 2; examples of some of these modalities may be found in Figure 3.",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "Figure 3 shows an example of both contrast-enhanced T1-weighted and T2-FLAIR MRI in a patient with a high-grade glioma.",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "Figure 3 shows an example of an ADC and FA map in a patient with a high-grade glioma.",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "Figure 2 shows a graphical representation of common mathematical terms employed to simplify the complex dynamics of tumor growth into two major contributing factors, proliferation, and invasion [21].",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "Figure 2: Graphical representation of diffusion, advection, and reaction (or proliferation) terms commonly employed in models of tumor growth and response.",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "Throughout this section the reader is referred to Figure 3 which illustrates how imaging has been used in the literature to inform mathematical models of tumor growth and response.",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "Figure 4 shows a schematic of the approach in Hormuth et al. where patient specific images are used to calibrate model parameters of response to radiotherapy.",
    "figure_references": [
      {
        "figure_number": "Figure 4",
        "panel": "",
        "figure_key": "figure_4"
      }
    ]
  },
  {
    "sentence": "Figure 4: Application of patient-specific quantitative MRI data to personalize models of tumor growth and response.",
    "figure_references": [
      {
        "figure_number": "Figure 4",
        "panel": "",
        "figure_key": "figure_4"
      }
    ]
  },
  {
    "sentence": "The reader is encouraged to refer to Figure 5 as they go through the following section as it provides one potential schema for this patient-oriented modeling approach.",
    "figure_references": [
      {
        "figure_number": "Figure 5",
        "panel": "",
        "figure_key": "figure_5"
      }
    ]
  },
  {
    "sentence": "Figure 5: Imaged-based modeling for optimization of radiotherapy and immunotherapy regimens.",
    "figure_references": [
      {
        "figure_number": "Figure 5",
        "panel": "",
        "figure_key": "figure_5"
      }
    ]
  },
  {
    "sentence": "Data types required\nCentral to developing a patient-focused modeling study is the availability of serial patient-specific data characterizing the disease status and treatment effect (Figure 5a).",
    "figure_references": [
      {
        "figure_number": "Figure 5",
        "panel": "Panel a",
        "figure_key": "figure_5"
      },
      {
        "figure_number": "Figure 5",
        "panel": "Panel a",
        "figure_key": "figure_5"
      }
    ]
  },
  {
    "sentence": "Patient imaging data (and other data types) collected prior to the start of treatment and either midway or at the conclusion of treatment could be used in a mathematical framework to predict individual patient response [16,160,237] (Figure 5b).",
    "figure_references": [
      {
        "figure_number": "Figure 5",
        "panel": "Panel b",
        "figure_key": "figure_5"
      },
      {
        "figure_number": "Figure 5",
        "panel": "Panel b",
        "figure_key": "figure_5"
      }
    ]
  },
  {
    "sentence": "Once the descriptive and predictive accuracy of the mathematical model is established, the mathematical framework can be employed to investigate alternative and potentially optimal treatment regimens aimed at improving tumor control (Figure 5c).",
    "figure_references": [
      {
        "figure_number": "Figure 5",
        "panel": "Panel c",
        "figure_key": "figure_5"
      },
      {
        "figure_number": "Figure 5",
        "panel": "Panel c",
        "figure_key": "figure_5"
      }
    ]
  },
  {
    "sentence": "Among other monoclonal antibody targets, nivolumab and pembrolizumab are monoclonal antibodies targeting PD-1 receptor on T cells, B cells and NK (natural killer) cells inhibiting its binding to PD-L1 (Figure 1a), allowing the positive signaling of IFN-γ (interferon gamma) and activating the intracellular expression of anti-proliferation and pro-apoptosis genes [3,5,36].",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "Panel a",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "Panel a",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "Figure 1: Mechanisms of action for immunotherapy as a monotherapy and the immunogenic effects of radiotherapy in brain tumors.",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "The CAR (Figure 1b) consists of an artificial B cell receptor with variable antigen receptor domain specific to a unique tumor expressed antigen fused with the T cells CD3 TCR (CD 3-zeta) intracytoplasmic domain.",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "Panel b",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "Panel b",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "The systemic increase in antigen recognition has been shown to induce T cell-mediated inhibition of untreated metastatic disease (the abscopal effect) [59,60] (Figure 1c).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "Panel c",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "Panel c",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "A summary of these imaging modalities and the quantities they measure is provided in Table 2; examples of some of these modalities may be found in Figure 3.",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "Figure 3 shows an example of both contrast-enhanced T1-weighted and T2-FLAIR MRI in a patient with a high-grade glioma.",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "Figure 3 shows an example of an ADC and FA map in a patient with a high-grade glioma.",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "Figure 2 shows a graphical representation of common mathematical terms employed to simplify the complex dynamics of tumor growth into two major contributing factors, proliferation, and invasion [21].",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "Figure 2: Graphical representation of diffusion, advection, and reaction (or proliferation) terms commonly employed in models of tumor growth and response.",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "Throughout this section the reader is referred to Figure 3 which illustrates how imaging has been used in the literature to inform mathematical models of tumor growth and response.",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "Figure 4 shows a schematic of the approach in Hormuth et al. where patient specific images are used to calibrate model parameters of response to radiotherapy.",
    "figure_references": [
      {
        "figure_number": "Figure 4",
        "panel": "",
        "figure_key": "figure_4"
      }
    ]
  },
  {
    "sentence": "Figure 4: Application of patient-specific quantitative MRI data to personalize models of tumor growth and response.",
    "figure_references": [
      {
        "figure_number": "Figure 4",
        "panel": "",
        "figure_key": "figure_4"
      }
    ]
  },
  {
    "sentence": "The reader is encouraged to refer to Figure 5 as they go through the following section as it provides one potential schema for this patient-oriented modeling approach.",
    "figure_references": [
      {
        "figure_number": "Figure 5",
        "panel": "",
        "figure_key": "figure_5"
      }
    ]
  },
  {
    "sentence": "Figure 5: Imaged-based modeling for optimization of radiotherapy and immunotherapy regimens.",
    "figure_references": [
      {
        "figure_number": "Figure 5",
        "panel": "",
        "figure_key": "figure_5"
      }
    ]
  },
  {
    "sentence": "Data types required\nCentral to developing a patient-focused modeling study is the availability of serial patient-specific data characterizing the disease status and treatment effect (Figure 5a).",
    "figure_references": [
      {
        "figure_number": "Figure 5",
        "panel": "Panel a",
        "figure_key": "figure_5"
      },
      {
        "figure_number": "Figure 5",
        "panel": "Panel a",
        "figure_key": "figure_5"
      }
    ]
  },
  {
    "sentence": "Patient imaging data (and other data types) collected prior to the start of treatment and either midway or at the conclusion of treatment could be used in a mathematical framework to predict individual patient response [16,160,237] (Figure 5b).",
    "figure_references": [
      {
        "figure_number": "Figure 5",
        "panel": "Panel b",
        "figure_key": "figure_5"
      },
      {
        "figure_number": "Figure 5",
        "panel": "Panel b",
        "figure_key": "figure_5"
      }
    ]
  },
  {
    "sentence": "Once the descriptive and predictive accuracy of the mathematical model is established, the mathematical framework can be employed to investigate alternative and potentially optimal treatment regimens aimed at improving tumor control (Figure 5c).",
    "figure_references": [
      {
        "figure_number": "Figure 5",
        "panel": "Panel c",
        "figure_key": "figure_5"
      },
      {
        "figure_number": "Figure 5",
        "panel": "Panel c",
        "figure_key": "figure_5"
      }
    ]
  },
  {
    "sentence": "Among other monoclonal antibody targets, nivolumab and pembrolizumab are monoclonal antibodies targeting PD-1 receptor on T cells, B cells and NK (natural killer) cells inhibiting its binding to PD-L1 (Figure 1a), allowing the positive signaling of IFN-γ (interferon gamma) and activating the intracellular expression of anti-proliferation and pro-apoptosis genes [3,5,36].",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "Panel a",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "Panel a",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "Figure 1: Mechanisms of action for immunotherapy as a monotherapy and the immunogenic effects of radiotherapy in brain tumors.",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "The CAR (Figure 1b) consists of an artificial B cell receptor with variable antigen receptor domain specific to a unique tumor expressed antigen fused with the T cells CD3 TCR (CD 3-zeta) intracytoplasmic domain.",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "Panel b",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "Panel b",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "The systemic increase in antigen recognition has been shown to induce T cell-mediated inhibition of untreated metastatic disease (the abscopal effect) [59,60] (Figure 1c).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "Panel c",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "Panel c",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "A summary of these imaging modalities and the quantities they measure is provided in Table 2; examples of some of these modalities may be found in Figure 3.",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "Figure 3 shows an example of both contrast-enhanced T1-weighted and T2-FLAIR MRI in a patient with a high-grade glioma.",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "Figure 3 shows an example of an ADC and FA map in a patient with a high-grade glioma.",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "Figure 2 shows a graphical representation of common mathematical terms employed to simplify the complex dynamics of tumor growth into two major contributing factors, proliferation, and invasion [21].",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "Figure 2: Graphical representation of diffusion, advection, and reaction (or proliferation) terms commonly employed in models of tumor growth and response.",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "Throughout this section the reader is referred to Figure 3 which illustrates how imaging has been used in the literature to inform mathematical models of tumor growth and response.",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "Figure 4 shows a schematic of the approach in Hormuth et al. where patient specific images are used to calibrate model parameters of response to radiotherapy.",
    "figure_references": [
      {
        "figure_number": "Figure 4",
        "panel": "",
        "figure_key": "figure_4"
      }
    ]
  },
  {
    "sentence": "Figure 4: Application of patient-specific quantitative MRI data to personalize models of tumor growth and response.",
    "figure_references": [
      {
        "figure_number": "Figure 4",
        "panel": "",
        "figure_key": "figure_4"
      }
    ]
  },
  {
    "sentence": "The reader is encouraged to refer to Figure 5 as they go through the following section as it provides one potential schema for this patient-oriented modeling approach.",
    "figure_references": [
      {
        "figure_number": "Figure 5",
        "panel": "",
        "figure_key": "figure_5"
      }
    ]
  },
  {
    "sentence": "Figure 5: Imaged-based modeling for optimization of radiotherapy and immunotherapy regimens.",
    "figure_references": [
      {
        "figure_number": "Figure 5",
        "panel": "",
        "figure_key": "figure_5"
      }
    ]
  },
  {
    "sentence": "Data types required\nCentral to developing a patient-focused modeling study is the availability of serial patient-specific data characterizing the disease status and treatment effect (Figure 5a).",
    "figure_references": [
      {
        "figure_number": "Figure 5",
        "panel": "Panel a",
        "figure_key": "figure_5"
      },
      {
        "figure_number": "Figure 5",
        "panel": "Panel a",
        "figure_key": "figure_5"
      }
    ]
  },
  {
    "sentence": "Patient imaging data (and other data types) collected prior to the start of treatment and either midway or at the conclusion of treatment could be used in a mathematical framework to predict individual patient response [16,160,237] (Figure 5b).",
    "figure_references": [
      {
        "figure_number": "Figure 5",
        "panel": "Panel b",
        "figure_key": "figure_5"
      },
      {
        "figure_number": "Figure 5",
        "panel": "Panel b",
        "figure_key": "figure_5"
      }
    ]
  },
  {
    "sentence": "Once the descriptive and predictive accuracy of the mathematical model is established, the mathematical framework can be employed to investigate alternative and potentially optimal treatment regimens aimed at improving tumor control (Figure 5c).",
    "figure_references": [
      {
        "figure_number": "Figure 5",
        "panel": "Panel c",
        "figure_key": "figure_5"
      },
      {
        "figure_number": "Figure 5",
        "panel": "Panel c",
        "figure_key": "figure_5"
      }
    ]
  },
  {
    "sentence": "Among other monoclonal antibody targets, nivolumab and pembrolizumab are monoclonal antibodies targeting PD-1 receptor on T cells, B cells and NK (natural killer) cells inhibiting its binding to PD-L1 (Figure 1a), allowing the positive signaling of IFN-γ (interferon gamma) and activating the intracellular expression of anti-proliferation and pro-apoptosis genes [3,5,36].",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "Panel a",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "Panel a",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "Figure 1: Mechanisms of action for immunotherapy as a monotherapy and the immunogenic effects of radiotherapy in brain tumors.",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "The CAR (Figure 1b) consists of an artificial B cell receptor with variable antigen receptor domain specific to a unique tumor expressed antigen fused with the T cells CD3 TCR (CD 3-zeta) intracytoplasmic domain.",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "Panel b",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "Panel b",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "The systemic increase in antigen recognition has been shown to induce T cell-mediated inhibition of untreated metastatic disease (the abscopal effect) [59,60] (Figure 1c).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "Panel c",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "Panel c",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "A summary of these imaging modalities and the quantities they measure is provided in Table 2; examples of some of these modalities may be found in Figure 3.",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "Figure 3 shows an example of both contrast-enhanced T1-weighted and T2-FLAIR MRI in a patient with a high-grade glioma.",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "Figure 3 shows an example of an ADC and FA map in a patient with a high-grade glioma.",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "Figure 2 shows a graphical representation of common mathematical terms employed to simplify the complex dynamics of tumor growth into two major contributing factors, proliferation, and invasion [21].",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "Figure 2: Graphical representation of diffusion, advection, and reaction (or proliferation) terms commonly employed in models of tumor growth and response.",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "Throughout this section the reader is referred to Figure 3 which illustrates how imaging has been used in the literature to inform mathematical models of tumor growth and response.",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "Figure 4 shows a schematic of the approach in Hormuth et al. where patient specific images are used to calibrate model parameters of response to radiotherapy.",
    "figure_references": [
      {
        "figure_number": "Figure 4",
        "panel": "",
        "figure_key": "figure_4"
      }
    ]
  },
  {
    "sentence": "Figure 4: Application of patient-specific quantitative MRI data to personalize models of tumor growth and response.",
    "figure_references": [
      {
        "figure_number": "Figure 4",
        "panel": "",
        "figure_key": "figure_4"
      }
    ]
  },
  {
    "sentence": "The reader is encouraged to refer to Figure 5 as they go through the following section as it provides one potential schema for this patient-oriented modeling approach.",
    "figure_references": [
      {
        "figure_number": "Figure 5",
        "panel": "",
        "figure_key": "figure_5"
      }
    ]
  },
  {
    "sentence": "Figure 5: Imaged-based modeling for optimization of radiotherapy and immunotherapy regimens.",
    "figure_references": [
      {
        "figure_number": "Figure 5",
        "panel": "",
        "figure_key": "figure_5"
      }
    ]
  },
  {
    "sentence": "Data types required\nCentral to developing a patient-focused modeling study is the availability of serial patient-specific data characterizing the disease status and treatment effect (Figure 5a).",
    "figure_references": [
      {
        "figure_number": "Figure 5",
        "panel": "Panel a",
        "figure_key": "figure_5"
      },
      {
        "figure_number": "Figure 5",
        "panel": "Panel a",
        "figure_key": "figure_5"
      }
    ]
  },
  {
    "sentence": "Patient imaging data (and other data types) collected prior to the start of treatment and either midway or at the conclusion of treatment could be used in a mathematical framework to predict individual patient response [16,160,237] (Figure 5b).",
    "figure_references": [
      {
        "figure_number": "Figure 5",
        "panel": "Panel b",
        "figure_key": "figure_5"
      },
      {
        "figure_number": "Figure 5",
        "panel": "Panel b",
        "figure_key": "figure_5"
      }
    ]
  },
  {
    "sentence": "Once the descriptive and predictive accuracy of the mathematical model is established, the mathematical framework can be employed to investigate alternative and potentially optimal treatment regimens aimed at improving tumor control (Figure 5c).",
    "figure_references": [
      {
        "figure_number": "Figure 5",
        "panel": "Panel c",
        "figure_key": "figure_5"
      },
      {
        "figure_number": "Figure 5",
        "panel": "Panel c",
        "figure_key": "figure_5"
      }
    ]
  },
  {
    "sentence": "Among other monoclonal antibody targets, nivolumab and pembrolizumab are monoclonal antibodies targeting PD-1 receptor on T cells, B cells and NK (natural killer) cells inhibiting its binding to PD-L1 (Figure 1a), allowing the positive signaling of IFN-γ (interferon gamma) and activating the intracellular expression of anti-proliferation and pro-apoptosis genes [3,5,36].",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "Panel a",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "Panel a",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "Figure 1: Mechanisms of action for immunotherapy as a monotherapy and the immunogenic effects of radiotherapy in brain tumors.",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "The CAR (Figure 1b) consists of an artificial B cell receptor with variable antigen receptor domain specific to a unique tumor expressed antigen fused with the T cells CD3 TCR (CD 3-zeta) intracytoplasmic domain.",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "Panel b",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "Panel b",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "The systemic increase in antigen recognition has been shown to induce T cell-mediated inhibition of untreated metastatic disease (the abscopal effect) [59,60] (Figure 1c).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "Panel c",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "Panel c",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "A summary of these imaging modalities and the quantities they measure is provided in Table 2; examples of some of these modalities may be found in Figure 3.",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "Figure 3 shows an example of both contrast-enhanced T1-weighted and T2-FLAIR MRI in a patient with a high-grade glioma.",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "Figure 3 shows an example of an ADC and FA map in a patient with a high-grade glioma.",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "Figure 2 shows a graphical representation of common mathematical terms employed to simplify the complex dynamics of tumor growth into two major contributing factors, proliferation, and invasion [21].",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "Figure 2: Graphical representation of diffusion, advection, and reaction (or proliferation) terms commonly employed in models of tumor growth and response.",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "Throughout this section the reader is referred to Figure 3 which illustrates how imaging has been used in the literature to inform mathematical models of tumor growth and response.",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "Figure 4 shows a schematic of the approach in Hormuth et al. where patient specific images are used to calibrate model parameters of response to radiotherapy.",
    "figure_references": [
      {
        "figure_number": "Figure 4",
        "panel": "",
        "figure_key": "figure_4"
      }
    ]
  },
  {
    "sentence": "Figure 4: Application of patient-specific quantitative MRI data to personalize models of tumor growth and response.",
    "figure_references": [
      {
        "figure_number": "Figure 4",
        "panel": "",
        "figure_key": "figure_4"
      }
    ]
  },
  {
    "sentence": "The reader is encouraged to refer to Figure 5 as they go through the following section as it provides one potential schema for this patient-oriented modeling approach.",
    "figure_references": [
      {
        "figure_number": "Figure 5",
        "panel": "",
        "figure_key": "figure_5"
      }
    ]
  },
  {
    "sentence": "Figure 5: Imaged-based modeling for optimization of radiotherapy and immunotherapy regimens.",
    "figure_references": [
      {
        "figure_number": "Figure 5",
        "panel": "",
        "figure_key": "figure_5"
      }
    ]
  },
  {
    "sentence": "Data types required\nCentral to developing a patient-focused modeling study is the availability of serial patient-specific data characterizing the disease status and treatment effect (Figure 5a).",
    "figure_references": [
      {
        "figure_number": "Figure 5",
        "panel": "Panel a",
        "figure_key": "figure_5"
      },
      {
        "figure_number": "Figure 5",
        "panel": "Panel a",
        "figure_key": "figure_5"
      }
    ]
  },
  {
    "sentence": "Patient imaging data (and other data types) collected prior to the start of treatment and either midway or at the conclusion of treatment could be used in a mathematical framework to predict individual patient response [16,160,237] (Figure 5b).",
    "figure_references": [
      {
        "figure_number": "Figure 5",
        "panel": "Panel b",
        "figure_key": "figure_5"
      },
      {
        "figure_number": "Figure 5",
        "panel": "Panel b",
        "figure_key": "figure_5"
      }
    ]
  },
  {
    "sentence": "Once the descriptive and predictive accuracy of the mathematical model is established, the mathematical framework can be employed to investigate alternative and potentially optimal treatment regimens aimed at improving tumor control (Figure 5c).",
    "figure_references": [
      {
        "figure_number": "Figure 5",
        "panel": "Panel c",
        "figure_key": "figure_5"
      },
      {
        "figure_number": "Figure 5",
        "panel": "Panel c",
        "figure_key": "figure_5"
      }
    ]
  },
  {
    "sentence": "Among other monoclonal antibody targets, nivolumab and pembrolizumab are monoclonal antibodies targeting PD-1 receptor on T cells, B cells and NK (natural killer) cells inhibiting its binding to PD-L1 (Figure 1a), allowing the positive signaling of IFN-γ (interferon gamma) and activating the intracellular expression of anti-proliferation and pro-apoptosis genes [3,5,36].",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "Panel a",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "Panel a",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "Figure 1: Mechanisms of action for immunotherapy as a monotherapy and the immunogenic effects of radiotherapy in brain tumors.",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "The CAR (Figure 1b) consists of an artificial B cell receptor with variable antigen receptor domain specific to a unique tumor expressed antigen fused with the T cells CD3 TCR (CD 3-zeta) intracytoplasmic domain.",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "Panel b",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "Panel b",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "The systemic increase in antigen recognition has been shown to induce T cell-mediated inhibition of untreated metastatic disease (the abscopal effect) [59,60] (Figure 1c).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "Panel c",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "Panel c",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "A summary of these imaging modalities and the quantities they measure is provided in Table 2; examples of some of these modalities may be found in Figure 3.",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "Figure 3 shows an example of both contrast-enhanced T1-weighted and T2-FLAIR MRI in a patient with a high-grade glioma.",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "Figure 3 shows an example of an ADC and FA map in a patient with a high-grade glioma.",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "Figure 2 shows a graphical representation of common mathematical terms employed to simplify the complex dynamics of tumor growth into two major contributing factors, proliferation, and invasion [21].",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "Figure 2: Graphical representation of diffusion, advection, and reaction (or proliferation) terms commonly employed in models of tumor growth and response.",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "Throughout this section the reader is referred to Figure 3 which illustrates how imaging has been used in the literature to inform mathematical models of tumor growth and response.",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "Figure 4 shows a schematic of the approach in Hormuth et al. where patient specific images are used to calibrate model parameters of response to radiotherapy.",
    "figure_references": [
      {
        "figure_number": "Figure 4",
        "panel": "",
        "figure_key": "figure_4"
      }
    ]
  },
  {
    "sentence": "Figure 4: Application of patient-specific quantitative MRI data to personalize models of tumor growth and response.",
    "figure_references": [
      {
        "figure_number": "Figure 4",
        "panel": "",
        "figure_key": "figure_4"
      }
    ]
  },
  {
    "sentence": "The reader is encouraged to refer to Figure 5 as they go through the following section as it provides one potential schema for this patient-oriented modeling approach.",
    "figure_references": [
      {
        "figure_number": "Figure 5",
        "panel": "",
        "figure_key": "figure_5"
      }
    ]
  },
  {
    "sentence": "Figure 5: Imaged-based modeling for optimization of radiotherapy and immunotherapy regimens.",
    "figure_references": [
      {
        "figure_number": "Figure 5",
        "panel": "",
        "figure_key": "figure_5"
      }
    ]
  },
  {
    "sentence": "Data types required\nCentral to developing a patient-focused modeling study is the availability of serial patient-specific data characterizing the disease status and treatment effect (Figure 5a).",
    "figure_references": [
      {
        "figure_number": "Figure 5",
        "panel": "Panel a",
        "figure_key": "figure_5"
      },
      {
        "figure_number": "Figure 5",
        "panel": "Panel a",
        "figure_key": "figure_5"
      }
    ]
  },
  {
    "sentence": "Patient imaging data (and other data types) collected prior to the start of treatment and either midway or at the conclusion of treatment could be used in a mathematical framework to predict individual patient response [16,160,237] (Figure 5b).",
    "figure_references": [
      {
        "figure_number": "Figure 5",
        "panel": "Panel b",
        "figure_key": "figure_5"
      },
      {
        "figure_number": "Figure 5",
        "panel": "Panel b",
        "figure_key": "figure_5"
      }
    ]
  },
  {
    "sentence": "Once the descriptive and predictive accuracy of the mathematical model is established, the mathematical framework can be employed to investigate alternative and potentially optimal treatment regimens aimed at improving tumor control (Figure 5c).",
    "figure_references": [
      {
        "figure_number": "Figure 5",
        "panel": "Panel c",
        "figure_key": "figure_5"
      },
      {
        "figure_number": "Figure 5",
        "panel": "Panel c",
        "figure_key": "figure_5"
      }
    ]
  },
  {
    "sentence": "Among other monoclonal antibody targets, nivolumab and pembrolizumab are monoclonal antibodies targeting PD-1 receptor on T cells, B cells and NK (natural killer) cells inhibiting its binding to PD-L1 (Figure 1a), allowing the positive signaling of IFN-γ (interferon gamma) and activating the intracellular expression of anti-proliferation and pro-apoptosis genes [3,5,36].",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "Panel a",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "Panel a",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "Figure 1: Mechanisms of action for immunotherapy as a monotherapy and the immunogenic effects of radiotherapy in brain tumors.",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "The CAR (Figure 1b) consists of an artificial B cell receptor with variable antigen receptor domain specific to a unique tumor expressed antigen fused with the T cells CD3 TCR (CD 3-zeta) intracytoplasmic domain.",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "Panel b",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "Panel b",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "The systemic increase in antigen recognition has been shown to induce T cell-mediated inhibition of untreated metastatic disease (the abscopal effect) [59,60] (Figure 1c).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "Panel c",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "Panel c",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "A summary of these imaging modalities and the quantities they measure is provided in Table 2; examples of some of these modalities may be found in Figure 3.",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "Figure 3 shows an example of both contrast-enhanced T1-weighted and T2-FLAIR MRI in a patient with a high-grade glioma.",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "Figure 3 shows an example of an ADC and FA map in a patient with a high-grade glioma.",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "Figure 2 shows a graphical representation of common mathematical terms employed to simplify the complex dynamics of tumor growth into two major contributing factors, proliferation, and invasion [21].",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "Figure 2: Graphical representation of diffusion, advection, and reaction (or proliferation) terms commonly employed in models of tumor growth and response.",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "Throughout this section the reader is referred to Figure 3 which illustrates how imaging has been used in the literature to inform mathematical models of tumor growth and response.",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "Figure 4 shows a schematic of the approach in Hormuth et al. where patient specific images are used to calibrate model parameters of response to radiotherapy.",
    "figure_references": [
      {
        "figure_number": "Figure 4",
        "panel": "",
        "figure_key": "figure_4"
      }
    ]
  },
  {
    "sentence": "Figure 4: Application of patient-specific quantitative MRI data to personalize models of tumor growth and response.",
    "figure_references": [
      {
        "figure_number": "Figure 4",
        "panel": "",
        "figure_key": "figure_4"
      }
    ]
  },
  {
    "sentence": "The reader is encouraged to refer to Figure 5 as they go through the following section as it provides one potential schema for this patient-oriented modeling approach.",
    "figure_references": [
      {
        "figure_number": "Figure 5",
        "panel": "",
        "figure_key": "figure_5"
      }
    ]
  },
  {
    "sentence": "Figure 5: Imaged-based modeling for optimization of radiotherapy and immunotherapy regimens.",
    "figure_references": [
      {
        "figure_number": "Figure 5",
        "panel": "",
        "figure_key": "figure_5"
      }
    ]
  },
  {
    "sentence": "Data types required\nCentral to developing a patient-focused modeling study is the availability of serial patient-specific data characterizing the disease status and treatment effect (Figure 5a).",
    "figure_references": [
      {
        "figure_number": "Figure 5",
        "panel": "Panel a",
        "figure_key": "figure_5"
      },
      {
        "figure_number": "Figure 5",
        "panel": "Panel a",
        "figure_key": "figure_5"
      }
    ]
  },
  {
    "sentence": "Patient imaging data (and other data types) collected prior to the start of treatment and either midway or at the conclusion of treatment could be used in a mathematical framework to predict individual patient response [16,160,237] (Figure 5b).",
    "figure_references": [
      {
        "figure_number": "Figure 5",
        "panel": "Panel b",
        "figure_key": "figure_5"
      },
      {
        "figure_number": "Figure 5",
        "panel": "Panel b",
        "figure_key": "figure_5"
      }
    ]
  },
  {
    "sentence": "Once the descriptive and predictive accuracy of the mathematical model is established, the mathematical framework can be employed to investigate alternative and potentially optimal treatment regimens aimed at improving tumor control (Figure 5c).",
    "figure_references": [
      {
        "figure_number": "Figure 5",
        "panel": "Panel c",
        "figure_key": "figure_5"
      },
      {
        "figure_number": "Figure 5",
        "panel": "Panel c",
        "figure_key": "figure_5"
      }
    ]
  },
  {
    "sentence": "Among other monoclonal antibody targets, nivolumab and pembrolizumab are monoclonal antibodies targeting PD-1 receptor on T cells, B cells and NK (natural killer) cells inhibiting its binding to PD-L1 (Figure 1a), allowing the positive signaling of IFN-γ (interferon gamma) and activating the intracellular expression of anti-proliferation and pro-apoptosis genes [3,5,36].",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "Panel a",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "Panel a",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "Figure 1: Mechanisms of action for immunotherapy as a monotherapy and the immunogenic effects of radiotherapy in brain tumors.",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "The CAR (Figure 1b) consists of an artificial B cell receptor with variable antigen receptor domain specific to a unique tumor expressed antigen fused with the T cells CD3 TCR (CD 3-zeta) intracytoplasmic domain.",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "Panel b",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "Panel b",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "The systemic increase in antigen recognition has been shown to induce T cell-mediated inhibition of untreated metastatic disease (the abscopal effect) [59,60] (Figure 1c).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "Panel c",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "Panel c",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "Among other monoclonal antibody targets, nivolumab and pembrolizumab are monoclonal antibodies targeting PD-1 receptor on T cells, B cells and NK (natural killer) cells inhibiting its binding to PD-L1 (Figure 1a), allowing the positive signaling of IFN-γ (interferon gamma) and activating the intracellular expression of anti-proliferation and pro-apoptosis genes [3,5,36].",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "Panel a",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "Panel a",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "Figure 1: Mechanisms of action for immunotherapy as a monotherapy and the immunogenic effects of radiotherapy in brain tumors.",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "The CAR (Figure 1b) consists of an artificial B cell receptor with variable antigen receptor domain specific to a unique tumor expressed antigen fused with the T cells CD3 TCR (CD 3-zeta) intracytoplasmic domain.",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "Panel b",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "Panel b",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "Among other monoclonal antibody targets, nivolumab and pembrolizumab are monoclonal antibodies targeting PD-1 receptor on T cells, B cells and NK (natural killer) cells inhibiting its binding to PD-L1 (Figure 1a), allowing the positive signaling of IFN-γ (interferon gamma) and activating the intracellular expression of anti-proliferation and pro-apoptosis genes [3,5,36].",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "Panel a",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "Panel a",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "The CAR (Figure 1b) consists of an artificial B cell receptor with variable antigen receptor domain specific to a unique tumor expressed antigen fused with the T cells CD3 TCR (CD 3-zeta) intracytoplasmic domain.",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "Panel b",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "Panel b",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "The systemic increase in antigen recognition has been shown to induce T cell-mediated inhibition of untreated metastatic disease (the abscopal effect) [59,60] (Figure 1c).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "Panel c",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "Panel c",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "The systemic increase in antigen recognition has been shown to induce T cell-mediated inhibition of untreated metastatic disease (the abscopal effect) [59,60] (Figure 1c).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "Panel c",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "Panel c",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "A summary of these imaging modalities and the quantities they measure is provided in Table 2; examples of some of these modalities may be found in Figure 3.",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "Figure 3 shows an example of both contrast-enhanced T1-weighted and T2-FLAIR MRI in a patient with a high-grade glioma.",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "Figure 3 shows an example of an ADC and FA map in a patient with a high-grade glioma.",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "A summary of these imaging modalities and the quantities they measure is provided in Table 2; examples of some of these modalities may be found in Figure 3.",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "Figure 3 shows an example of both contrast-enhanced T1-weighted and T2-FLAIR MRI in a patient with a high-grade glioma.",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "Figure 3 shows an example of both contrast-enhanced T1-weighted and T2-FLAIR MRI in a patient with a high-grade glioma.",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "Figure 3 shows an example of an ADC and FA map in a patient with a high-grade glioma.",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "Figure 3 shows an example of an ADC and FA map in a patient with a high-grade glioma.",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "Figure 2 shows a graphical representation of common mathematical terms employed to simplify the complex dynamics of tumor growth into two major contributing factors, proliferation, and invasion [21].",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "Figure 2: Graphical representation of diffusion, advection, and reaction (or proliferation) terms commonly employed in models of tumor growth and response.",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "Figure 2 shows a graphical representation of common mathematical terms employed to simplify the complex dynamics of tumor growth into two major contributing factors, proliferation, and invasion [21].",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "Throughout this section the reader is referred to Figure 3 which illustrates how imaging has been used in the literature to inform mathematical models of tumor growth and response.",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "Figure 4 shows a schematic of the approach in Hormuth et al. where patient specific images are used to calibrate model parameters of response to radiotherapy.",
    "figure_references": [
      {
        "figure_number": "Figure 4",
        "panel": "",
        "figure_key": "figure_4"
      }
    ]
  },
  {
    "sentence": "Figure 4: Application of patient-specific quantitative MRI data to personalize models of tumor growth and response.",
    "figure_references": [
      {
        "figure_number": "Figure 4",
        "panel": "",
        "figure_key": "figure_4"
      }
    ]
  },
  {
    "sentence": "Throughout this section the reader is referred to Figure 3 which illustrates how imaging has been used in the literature to inform mathematical models of tumor growth and response.",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "Throughout this section the reader is referred to Figure 3 which illustrates how imaging has been used in the literature to inform mathematical models of tumor growth and response.",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "Figure 4 shows a schematic of the approach in Hormuth et al. where patient specific images are used to calibrate model parameters of response to radiotherapy.",
    "figure_references": [
      {
        "figure_number": "Figure 4",
        "panel": "",
        "figure_key": "figure_4"
      }
    ]
  },
  {
    "sentence": "Figure 4: Application of patient-specific quantitative MRI data to personalize models of tumor growth and response.",
    "figure_references": [
      {
        "figure_number": "Figure 4",
        "panel": "",
        "figure_key": "figure_4"
      }
    ]
  },
  {
    "sentence": "Figure 4 shows a schematic of the approach in Hormuth et al. where patient specific images are used to calibrate model parameters of response to radiotherapy.",
    "figure_references": [
      {
        "figure_number": "Figure 4",
        "panel": "",
        "figure_key": "figure_4"
      }
    ]
  },
  {
    "sentence": "The reader is encouraged to refer to Figure 5 as they go through the following section as it provides one potential schema for this patient-oriented modeling approach.",
    "figure_references": [
      {
        "figure_number": "Figure 5",
        "panel": "",
        "figure_key": "figure_5"
      }
    ]
  },
  {
    "sentence": "Figure 5: Imaged-based modeling for optimization of radiotherapy and immunotherapy regimens.",
    "figure_references": [
      {
        "figure_number": "Figure 5",
        "panel": "",
        "figure_key": "figure_5"
      }
    ]
  },
  {
    "sentence": "Data types required\nCentral to developing a patient-focused modeling study is the availability of serial patient-specific data characterizing the disease status and treatment effect (Figure 5a).",
    "figure_references": [
      {
        "figure_number": "Figure 5",
        "panel": "Panel a",
        "figure_key": "figure_5"
      },
      {
        "figure_number": "Figure 5",
        "panel": "Panel a",
        "figure_key": "figure_5"
      }
    ]
  },
  {
    "sentence": "Patient imaging data (and other data types) collected prior to the start of treatment and either midway or at the conclusion of treatment could be used in a mathematical framework to predict individual patient response [16,160,237] (Figure 5b).",
    "figure_references": [
      {
        "figure_number": "Figure 5",
        "panel": "Panel b",
        "figure_key": "figure_5"
      },
      {
        "figure_number": "Figure 5",
        "panel": "Panel b",
        "figure_key": "figure_5"
      }
    ]
  },
  {
    "sentence": "Once the descriptive and predictive accuracy of the mathematical model is established, the mathematical framework can be employed to investigate alternative and potentially optimal treatment regimens aimed at improving tumor control (Figure 5c).",
    "figure_references": [
      {
        "figure_number": "Figure 5",
        "panel": "Panel c",
        "figure_key": "figure_5"
      },
      {
        "figure_number": "Figure 5",
        "panel": "Panel c",
        "figure_key": "figure_5"
      }
    ]
  },
  {
    "sentence": "The reader is encouraged to refer to Figure 5 as they go through the following section as it provides one potential schema for this patient-oriented modeling approach.",
    "figure_references": [
      {
        "figure_number": "Figure 5",
        "panel": "",
        "figure_key": "figure_5"
      }
    ]
  },
  {
    "sentence": "Data types required\nCentral to developing a patient-focused modeling study is the availability of serial patient-specific data characterizing the disease status and treatment effect (Figure 5a).",
    "figure_references": [
      {
        "figure_number": "Figure 5",
        "panel": "Panel a",
        "figure_key": "figure_5"
      },
      {
        "figure_number": "Figure 5",
        "panel": "Panel a",
        "figure_key": "figure_5"
      }
    ]
  },
  {
    "sentence": "Central to developing a patient-focused modeling study is the availability of serial patient-specific data characterizing the disease status and treatment effect (Figure 5a).",
    "figure_references": [
      {
        "figure_number": "Figure 5",
        "panel": "Panel a",
        "figure_key": "figure_5"
      },
      {
        "figure_number": "Figure 5",
        "panel": "Panel a",
        "figure_key": "figure_5"
      }
    ]
  },
  {
    "sentence": "Patient imaging data (and other data types) collected prior to the start of treatment and either midway or at the conclusion of treatment could be used in a mathematical framework to predict individual patient response [16,160,237] (Figure 5b).",
    "figure_references": [
      {
        "figure_number": "Figure 5",
        "panel": "Panel b",
        "figure_key": "figure_5"
      },
      {
        "figure_number": "Figure 5",
        "panel": "Panel b",
        "figure_key": "figure_5"
      }
    ]
  },
  {
    "sentence": "Once the descriptive and predictive accuracy of the mathematical model is established, the mathematical framework can be employed to investigate alternative and potentially optimal treatment regimens aimed at improving tumor control (Figure 5c).",
    "figure_references": [
      {
        "figure_number": "Figure 5",
        "panel": "Panel c",
        "figure_key": "figure_5"
      },
      {
        "figure_number": "Figure 5",
        "panel": "Panel c",
        "figure_key": "figure_5"
      }
    ]
  },
  {
    "sentence": "Patient imaging data (and other data types) collected prior to the start of treatment and either midway or at the conclusion of treatment could be used in a mathematical framework to predict individual patient response [16,160,237] (Figure 5b).",
    "figure_references": [
      {
        "figure_number": "Figure 5",
        "panel": "Panel b",
        "figure_key": "figure_5"
      },
      {
        "figure_number": "Figure 5",
        "panel": "Panel b",
        "figure_key": "figure_5"
      }
    ]
  },
  {
    "sentence": "Once the descriptive and predictive accuracy of the mathematical model is established, the mathematical framework can be employed to investigate alternative and potentially optimal treatment regimens aimed at improving tumor control (Figure 5c).",
    "figure_references": [
      {
        "figure_number": "Figure 5",
        "panel": "Panel c",
        "figure_key": "figure_5"
      },
      {
        "figure_number": "Figure 5",
        "panel": "Panel c",
        "figure_key": "figure_5"
      }
    ]
  }
]